For vaccine makers, a year of consolidation
It should be another good year, but share prices may have limited upside.
Month: February 2022
Microsoft shows that it’s game on
It has outperformed the market over the past two years as the pandemic played to its work-from-home strengths.
Nutrien sees gain on Ukraine uncertainty
Sees production increase if rival producers in Russia and Belarus face sanctions.
A look at the Ark Innovation Canadian fund
In Canada, ARK Investment actively manages five ETFs as a sub-advisor for Emerge Canada.
ARK Innovation’s Cathie Wood unphased by tech rout
She believes selloff is overdone and setting the stage for another rise.
For renewables, a year of wait and hope
Last year was expected to be a big one for renewable energy companies after a breakthrough in 2020. U.S. PresidentContinue Reading
